OPINION

Washington Insider: A New Report

Washington Insider: A New Report

Back Talk: Hail to the . . . CEO?

Back Talk: Hail to the . . . CEO?

Private View: Bonnie Overton

Private View: Bonnie Overton

Partner Forum: Will predictive analytics sell?

Can predictive analytics, embedded into CRM, fulfill the promise on which closed-loop marketing fell short: Allow pharma to harness data from rep visits to make their upcoming digital sales pitches smarter?

What Wearables Can Deliver for Marketers

What Wearables Can Deliver for Marketers

Excitement about wearables like the Apple Watch or Fitbit sometimes fuels unrealistic hype about healthcare marketing opportunities.

Will Pharma Have an Ashley Madison Moment?

Will Pharma Have an Ashley Madison Moment?

Ashley Madison's lesson must be heeded. For all the good pharma has done for the world, it has also created its share of ethical quagmires.

Editor's Desk: Kim Kardashian West's tempest in a bottle

Editor's Desk: Kim Kardashian West's tempest in a bottle

Could Kardashian West's now-notorious Diclegis social post be more than an OPDP case study?

Can Marketing Accelerate the Health Insurance Buying Cycle?

Can Marketing Accelerate the Health Insurance Buying Cycle?

Some folks move through their healthcare buying cycle relatively quickly and others may take a year, but everyone generally goes through the phases of discovering a need, shopping around, narrowing the field and making a decision.


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.